A Multi-Center, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with Acute Kidney Injury

MLA

James A Tumlin, et al. “A Multi-Center, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with Acute Kidney Injury.” PLOS ONE, vol. 10, Aug. 2015, p. e0132482. EBSCOhost, https://doi.org/10.1371/journal.pone.0132482.

APA

James A Tumlin, Claude M Galphin, Ashita J Tolwani, Micah R Chan, Anitha Vijayan, Kevin Finkel, Balazs Szamosfalvi, Devasmita Dev, J Ricardo DaSilva, Brad C Astor, Alexander S Yevzlin, H David Humes, & SCD Investigator Group. (2015). A Multi-Center, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with Acute Kidney Injury. PLOS ONE, 10, e0132482. https://doi.org/10.1371/journal.pone.0132482

Chicago

James A Tumlin, Claude M Galphin, Ashita J Tolwani, Micah R Chan, Anitha Vijayan, Kevin Finkel, Balazs Szamosfalvi, et al. 2015. “A Multi-Center, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with Acute Kidney Injury.” PLOS ONE 10 (August): e0132482. doi:10.1371/journal.pone.0132482.